RAYBURKE, MA 2'3 placed on a continuum where optimal health is assigned a value of 1.0 and health judged equivalent to death is assigned a value of 0.0.
To date, no one has systematically OBJECTIVE --Cost-utility analyses use information on health utilities to compare medical quantified the degree to which type 1 and treatments that have different clinical outcomes and impacts on survival. The purpose of this study was to describe the health utilities associated with diabetes and its treatments, complicatype 2 diabetes and their treatments, complications, and comorbidities affect quallions, andcomorbidities, ity of life. In published economic RESEARCH DESIGN AND METHODS--We studied 2,048 subjects with type 1 and analyses, empirical health utility scores type 2 diabetes recruited from specialty clinics at a university medical center. We administered were often not available. Instead, health a questionnaire to each individual to assess demographic characteristics, type and duration of utility scores were derived from theoretidiabetes, treatments, complications, and c0morbidities, and we used the Self-Administered cal constructs, the judgment of experiQuality of Well Being index (QWB-SA) to calculate a health utility score. We then created enced physicians, expert panels, regression models to fit the QWB-SA-derived health utility scores to indicator variables for type community surveys, and patients (2-5). 1 and type 2 diabetes and each demographic variable, treatment, and complication. The coeffi-
The lack of standardized and consistent dents were arranged in clinically meaningful ways tO develop models to describe penalties from thehealth utility scores for nonobese diabetic men without additional treatments, complications, health utility scores for the array of treatments and the microvascular, neuroorcomorbidities, pathic, and macrovascularhealth states
RESULTS--
The utility scores for nonobese diet-controlled .men and women with type 2 associated with diabetes has constrained diabetes and no microvascular, neuropathic, or cardiovascular complications were 0.69 and researchers' abilities to conduct cost-0.65, respectively. The utility scores for men and women with type 1 diabetes and no compliutility analyses and to credibly compare cations were slightly lower (0.67 and 0.64, respectively). Blindness, dialysis, symptomatic neutheir results. This has been recognized as ropathy, foot ulcers, amputation, debilitating stroke, and congestive heart failure were associated an important limitation of these economic withlower utility scores, analyses (1, 6) .
CONCLUSIONS
--Major diabetes complications are associated with worse health-related The availability of the Self-Adminisquality of life. The health utility scores provided should facilitate studies of the health burden of tered Quality of Well-Being index (QWBdiabetes and the cost-utility of alternative strategies for the prevention and treatment of diabetes. SA) makes it feasible to rapidly assess health utilities from large numbers of subDiabetes Care 25:2238 Care 25: -2243 Care 25: , 2002 jects in diverse health states using a standardized self-administered instrument, and is also makes if feasible to derive es--utility analyses are a type of ecov_val (1 The protocol for this study was re-ease, hypertension, and hypercholesterolgamble, the time trade-off methodology viewed and approved by the University of emia. In general, disease state variables requires extensive interviewer training, Michigan and the Centers for Disease were based on the subject's report tha{ the careful description of the proposed health .Control institutional review boards. Of disease state was diagnosed by a health state, and substantial subject time. In adthe candidates approached, 88% particicare provider. dition, both methods measure how an in-pared in the study, and all subjects proMedians and 25th and 75th interdividual, rather than the general public, vided written informed consent. A total of quartile ranges are reported for continuvalue a given health state.
2,048 patients with type 1 or type 2 dia-ous variables, and frequencies and To simplify the assessment of health betes who attended endocrinology, dia-proportions are reported for categorical utilities and to provide health utility estibetes, and ophthalmology clinics at the variables. Statistical significance of differmates from the perspective of the general University of Michigan Health System beences between groups was assessed with public, multi-attribute utility models tween 29 June 1998 and 15 March 2001 Wilcoxon's rank-sum test for continuous were developed (1) . Such multi-attribute were studied cross-sectionally. Because of variables and the Pearson X2 test for cateutility modds include the EuroQol (EQmissing values, 7 subjects were not alas-gorical variables. 5D), the Health Utilities Index (HUI) and sifted by type of diabetes; therefore, analThe QWB-SA-derived health utility the Quality of Well Beingindex (QWB).
yses used a total of 2,041 subjects, scores were fit by a multiple linear regres-QWB is an extensively applied multiEligibility requirements included age sion model to demographic and disease attribute utility model derived from corn->-18 years, a diagnosis of type 1 or type 2 state variables separately for each type of munity-based preference assessments (8) .
diabetes, ability to give informed consent, diabetes. Variables with multiple CategoThe QWBhas been widelyused in clinical and ability to either self-administer the ries were represented by indicator varitrials and studies to evaluate medical and questionnaires or, if visuallyimpaired, to ables. In the fitting process, all variables surgical therapies (9-11). A maj or limitarespond to a research assistant reading the were initially entered into the regression tion of the QWB is that it requires a questionnaires, model. We computed the estimates of the trained interviewer. Furthermore, the Two questionnaires were adminisvariables, and we noted those variables QWB questionnaire is long and complex tered: the Diabetes Staging Questionnaire with adjacent levels that were not in order and uses branching and probe questions.
(DSQ) and the QWB-SA. The DSQ was of increasing severity. Adjacent inconsisTo address the limitations of the devdoped to stage an individual's type tently ordered levels of one variable were QWB, deand duration of diabetes, treatment, cornthen combined, and the model was run veloped a self-administered version of the plications, and comorbidities. The DSQ again. The process was repeated in a step-QWB (QWB-SA) that takes < 10 min to was adapted from two instruments avail-wise fashion until the ordering of all varicomplete. The QWB-SA is a comprehenable from the Michigan Diabetes Research able coefficients increased in severity. sive measure of heakh rdated quality of and Training Center: the Diabetes Care Because our primary interest was to life that includes several components.
Profile (DCP) and the Diabetes Medical model the QWB-SA-derived health utilFirst, it includes three separate scales of History (DMH). The DCP includes quesity score as a function of a wide range of patient-reported levels of functioning: tions about demographics, age at onset of treatments and complications, all varimobility, physical activity, and social ac-diabetes; symptoms, and limitations on ables ordered in increasing severity were tivity. Second, each patient identifies performing activities of daily living that kept in the model, regardless of P value. symptoms or problems that may have af-are caused by diabetes. The DMH includes
The final coefficients of the indicator varifected him or her over the past 3 days questions on type and duration of diabeables represent the penalty associated from a list of 58 items. Then, the reported tes, treatment (insulin and oral medicawith each variable. When a coefficient levels of functioning and the subjective tions), complications, and comorbidities, was greater than zero_indicating that the symptomatic complaints are weighted by Study candidates were approached in complication was not associated with a the preferences of an independent sample the clinics at the time of routinely schedpenalty--the corresponding variable was of judges. Using this system, it is possible uled appointments. Subjects were asked omitted from the model. Penalty functo place the general health status of any to complete the DSQ before starting the tions, when subtracted from the health (14) 276 (22) the mean health utility score for dietTreated with medications 133 (17) 459 (37) controlled nonobese diabetic men withData are median (interquartile range) or frequency (%). Stroke with residual: stroke with any persistent out microvascular, neuropathic, or difficultyspeaking,any weakness,or difficultiesperformingdaily activitiesor working.TIA, transient cardiovascular complications. In type 2 ischemicattack, diabetes,obese subjectsand subjects treated with oral antidiabetic agents, inutility scores for diet-controllednonobese group, and by calculating the mean sulin, and antihypertensive agents had male subjects without diabetic complica-QWB-SA-derived health utility score for slightly lower health utility scores. Blindtions, formed an additive model to exall of the subjects in that group. The marness, dialysis, symptomatic neuropathy, plain the QWB-SA-derived health utility ginal means are interpreted as the mean foot ulcers, amputation, stroke, and conscore for any combination of treatments QWB-SA-derived health utility score for gestive heart failure were associated with and complications, each demographic, treatment, or complimore substantial reductions in quality of Using the final model for each type of cation group, not controlling for other life (0.052-0.170). Age, race, education, diabetes, marginal means were obtained variables, age at onset of diabetes, duration of diaby subsetting subjects in each demoIn both models, interaction terms bebetes, and cholesterol status were not asgraphic, treatment, and complication tween variables were considered using a sociated with significant reductions in health utility scores and were excluded ling for other variables. The marginal tensive drugs. Health utility scores were from the analysis, mean health utility scores for individual substantially lower in type 2 diabetic subIn type 1 diabetes, the intercept value complication states ranged from 0.528 jects with blindness, dialysis, symptomof 0.672 can be interpreted as the mean (tingling and burning) to 0.361 (blind in atic neuropathy, foot ulcers, amputation, health utility score for diabetic men both eyes) in type 2 diabetes and from stroke, and congestive heart failure. Simwithout microvascular, neuropathic, or 0.545 (tingling and burning) to 0.347 ilarly, in type 1 diabetes, health utility cardiovascular complications. Obese (blind m both eyes) in type 1 diabetes, scores were slightly lower in women and subj ects, subjects with diabetic kidney
In both type 2 and type 1 diabetes, all obese individuals, in subjects treated with disease, and those treated with antihyperinteraction effects measured by the re-antihypertensive drugs, and in those with tensive agents had slightly lower health sponse surface regression had P values diabetic kidney disease. Health utility utility scores. Blindness, symptomatic -->0.05; therefore, none were included in scores were substantially lower in type 1 neuropathy, foot ulcers, amputation,conthe models. Both models fit the data diabetic subjects with blindness, sympgestive heart failure, and debilitating moderately well (adjusted R2 = 36.3 tomatic neuropathy, foot ulcers, amputastroke were associated with more suband 45.0% for type 2 and type 1 diabetes, tion, debilitating stroke, and congestive stantial reductions in quality of life respectively) and did not show a signifi-heart failure. (0.058-0.208).
Compared with having cant lack of fit (P = 0.643 and 0.664, The health utility scores for people some college education, havingless than a respectively), with diabetes are generally in keeping high school education was associated with those for otherpopulations.For exwith a small reduction in health utility CONCLUSIONS--In this study, we ample, the mean QWB scores were 0.81 scores. Because only 7% of subjects had derived health utility scores by systematfor the general population in San Diego, less than a high school education and beically applying the QWB-SA to a large and CA; 0.70 for healthy adults -> 65 years of cause education was not otherwise assodiverse group of diabetic subjects with a age; 0.66 for adults with chronic obstrucciated with health utility scores, we variety of treatments, complications, and tire pulmonary disease; 0.64 for subjects elected not to include education in the comorbidities. In type 2 and type 1 dia-with osteoarthritis; and 0.61 for AIDS paanalysis. Age, race, age at onset of diabebetes, diet-controlled nonobese diabetic tients in a clinical trial (9, (16) (17) (18) (19) . tes, duration of diabetes, and cholesterol men without microvascular, neuropathic, Marginal means represent the mean status were not associated with significant or cardiovascular complications had the health utility scores for individuals in reductions in health utility scores and highest health utility scores (0.69 for type each demographic, treatment, and cornwere also excluded from the analysis.
2 diabetes and 0.67 for type 1 diabetes), plication state without controlling for The marginal mean utility scores for
In type 2 diabetes, health utility scores other variables. The marginal means decomplication states represent the mean were slightly lower in women and obese rived from our study population do not health utility scores for individuals with subjects and in those treated with oral anreflect those for a general diabetic popuspecific complications, without controltidiabetic agents, insulin, and antihyperlation because we oversampled subjects with advanced complications. Although vascular complications had significantly cross-walk mapping between the most the reductions in health utility scores as-lower scores than those without complipopular utility-based measures. sociated with dialysis were small, and cations. This study differed from ours in Two limitations of our study deserve they were smaller for subjects with type 1 several ways. First, subjects in the UKPDS special mention. First, our decision to use diabetes than for subjects with type 2 di-represented a relatively homogenous indiabetic subjects drawn from clinics at a abetes (-0.023 and -0.078, respective- cidence cohort with type 2 diabetes. Our tertiary care referral center was based on ly), the marginal mean utility scores for population included type 1 and type 2 our desire to oversample subjects with adtype 1 and type 2 diabetic subjects receivdiabetic subjects with a wide range of du-vanced diabetic complications and to ing dialysis were 0.453 and 0.404, respecrations of disease, treatments, complicamodel the impact of individual complicatively. This reflects the presence of tions, and comorbidities. In addition, the tions and comorbidities.
Because the multiple concurrent complications in UKPDS group assessed health utility QWB-SA, by its design, derives the prefthese subjects. Not unexpectedly, the scores with the EQ-5D, whereas we used erences or utilities that the general public marginal means were <0.500 in both the QWB-SA. The EQ-5D measures only has for particular symptoms and functype 1 and type 2 diabetic subjects with three levels of functions on five domains, tional states, it was not critical or even other advanced chronic complications, whereas the QWB-SA measures multiple desirable that respondents to the including blindness in both eyes, ampulevels of function on three domains and QWB-SA be representative of the popularation, stroke, and congestive heart failure.
58 specific symptoms and health .probtion, only that the societal judges be rep-A recent review that reported 1,000 lems. Because of these differences, the resentative of the community. The measures of quality of life identified just QWB might be expected to be more senpenalty functions in Table 2 provide an one health utility score for diabetes sitive to small differences in health. Fi-additive modelto calculate thehealthutil-(20,21). We found only four studies that nally, the UKPDS did not assess the ity score for any combination of treatpresented empirically derived health utilassociation among individual microvasments, complications, and comorbidities ity scores for diabetes (22) (23) (24) (25) . However, cular and macrovascular complications and are not affected by the distribution of these studies did not systematically inand utility scores, whereas we created re-subjects with complications. The marclude health utility scores for individual gression models to fit health utility scores ginal mean utility scores in Table 2 are microvascular and macrovascular complications and comorbidities in type i and to type of diabetes and each demographic not, however, representative of those for the general diabetic population because type 2 diabetes. In general, health utility variable, treatment, and complication, we oversampled subjects with advanced Recently, Redekop et al. (24) assessed complications, and they may not apply to scores were indirectly'assessed, assessed health utility scores by applying the Eurothe general diabetic population. with potentially less,sensitive instruQol to a sample of Dutch type 2 diabetic Second, we chose to define diabetes ments,diabeticOrpatients.reported only for subgroups of subjects who participated in the Cost of health status by self-report rather than by Wu et al. (22) estimated health utility Diabetes in Europe -Type 2 (CODE-2) more objective testing. Our purpose in scores for subjects with type 1 diabetes, study. Older age, obesity, female sex, indoing so was to reflect both the natural using health status data derived from the sulin therapy, and presence of complicahistory of disease and to categorize comtions were associated with lower health SF-36 and a published empirical regresplications accordingto the stagesat which sion equation (26), to predict QWB utility, scores. Like the UKPDS analysis, either the complication or its treatment scores. The regression equation drew on this study did not assess health utility would impact symptoms and functionfive of eight SF-36 domains and predicted scores for specific microvascular and maing. The focus is thus on individual 56.9% of the observed variance in the crovascular complications, awareness of complications, symptoms of QWB-derived health utility scores. Pre-.
Ragnarson Tennvall and Apelqvist complications, or treatments for complidicted QWB scores were stratified by age (25) also assessed health utility scores in cations that would likely affect quality of and reported for individuals with no corndiabetic patients with foot complications life. Because the focus of staging is on plications, with retinopathy, and with by applying the EuroQol questionnaire, complications that affect symptoms and other complications. Age was inversely
In this subgroup of diabetic subjects, infunctioning and not anatomy and physicorrelated with predicted QWB scores. In dividuals with major amputations and ology, we believe that it is indeed more subjects <65 years of age, health utility current foot ulcers had lower health utilappropriate to collect diabetes staging scores were lower in subjects without comity scores than those with primary healed data by self-report (e.g., questionnaire) plications than in those with retinopathy, ulcers, rather than by medical record review or In subjects ->65 years of age, health utility As is apparent, there are several alterobjective testing (fundus'photographs, scores were higher in those without corn-'native methods for rapidly assessing biochemical testing, etc.). plications than in those with retinopathy, health utility scores. In addition to the In summary, these empirically deThe U.K. Prospective Diabetes Study QWB-SA, there is the HUI (27) and the rived health utility scores will allow re-(UKPDS) Group directly assessed health EuroQol (EQ-5D) (28). These three searchers to calculate QALYs for studies utility scores in type 2 diabetes by applymethods are not strictly comparable. As a involving subjects with type 1 and type 2 ing the EQ-5D questionnaire (EuroQol) result, the health utility scores obtained in' diabetes and a wide variety of treatments, (23). Subjects with microvascular comthis study would correlate with those obcomplications, and comorbidities. The plications had slightly, but not signifirained with the EQ-SD and HUI but may health utility scores provided should facandy, lower scores than patients without not be directly interchangeable. Studies cilitate studies of the health burden of dicomplications, and subjects with macroare underway in an attempt to develop abetes and the cost-utility of alternative
